Neural operator-based digital twins for modeling amyloid-β and tau propagation and treatment optimization in Alzheimer's disease
Authors: Xiaofeng Xu, Tingting Dan, Zifan Zhou, Bin Li, Guorong Wu, Wenrui Hao
Organizations: Department of Mathematics, Pennsylvania State University, University Park, PA 16802, USA · Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA · School of Electrical Engineering and Computer Science, Pennsylvania State University, University Park, PA 16802, USA · Department of Computer Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA · Department of Statistics and Operation Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA · UNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Accurately predicting the spatiotemporal evolution of amyloid-β and tau proteins at the individual level is critical for improving the diagnosis and treatment of Alzheimer's disease. We consider the problem of constructing patient-specific digital twins that model the propagation of these biomarkers on the cortical surface using reaction--diffusion dynamics. A major challenge is that the underlying nonlinear aggregation mechanisms are unknown and must be inferred from sparse, noisy, and heterogeneous longitudinal PET imaging data. To address this, we develop a data-driven framework that learns biomarker dynamics directly from clinical observations. The approach combines operator learning with reduced-order representations to infer governing equations of disease progression from data. Using this framework, we achieve predictive accuracies of 87% for amyloid-β and 81% for tau. Building on the learned dynamics, we further formulate a PDE-constrained optimal control problem to design personalized therapeutic strategies that regulate pathological protein propagation. By integrating data-driven dynamical modeling with treatment optimization, the proposed digital twin framework provides an interpretable and predictive platform for understanding disease progression and enabling precision interventions in neurodegenerative disorders.